Immunosuppressive

DRUG3 trials

Sponsors

Chiesi Farmaceutici S.p.A., Spanish Network for Research in Infectious Diseases, University of Rome Tor Vergata

Conditions

5 Years of Follow-up After Transplant, in Which an Attempt Was Made to Suspend ISCOVID-19 InfectionKidney TransplantSingle Transplant

Unknown Phase

The Adherence of Immunosuppressive Therapy Including Tacrolimus Once-daily in Italian Kidney Transplant Recipients

CompletedNCT03558373

Chiesi Farmaceutici S.p.A.Kidney Transplant

Start: 2018-07-31End: 2020-02-26Updated: 2022-05-05

Immunosupressive Treatment in COVID-19 Patients

Spanish Network for Research in Infectious DiseasesCOVID-19 Infection

Start: 2020-05-31End: 2020-05-31Target: 500Updated: 2020-05-12

De Novo Metabolic Syndrome in Liver Transplant Patients After Immunosuppression Withdrawal

CompletedNCT05808192

University of Rome Tor Vergata5 Years of Follow-up After Transplant, in Which an Attempt Was Made to Suspend IS, Single Transplant

Start: 2020-09-01End: 2022-05-01Updated: 2023-04-11